Extrapyramidal Side Effects.
D'Souza RS, Aslam SP, Hooten WM.
2025 Jan 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Akathisia as an Extrapyramidal Side Effect of Fluoxetine.
Ajufo I, Basiru TO.
Cureus. 2021 Jun 21;13(6):e15797. doi: 10.7759/cureus.15797. eCollection 2021 Jun.
Extrapyramidal side effects with nonantipsychotic medications.
Koch J, Launio M, Williams AM.
Ment Health Clin. 2024 Aug 2;14(4):233-235. doi: 10.9740/mhc.2024.08.233. eCollection 2024 Aug.
A 'benign' extrapyramidal side effect masking a life-threatening neuroleptic malignant syndrome.
Dolp R, Ansari MA, Chan M, Hassan T.
Pak J Med Sci. 2020 Sep-Oct;36(6):1429-1432. doi: 10.12669/pjms.36.6.2963.
Olanzapine.
Hale AS.
Br J Hosp Med. 1997 Nov 5-18;58(9):442-5.
Treatment of schizophrenia.
Beckmann B, Hippius H, Rüther E.
Prog Neuropsychopharmacol. 1979;3(1-3):47-52. doi: 10.1016/0364-7722(79)90068-7.
New Drugs III.
[No authors listed]
1997 Aug. Perry T, editor. Therapeutics Letter. Vancouver (BC): Therapeutic Initiatives; 1994–. Letter 20.
Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist.
Sumi S, Nagamine T, Sumi K, Aijima R, Oka K, Toyofuku A.
Front Psychiatry. 2022 Sep 6;13:976387. doi: 10.3389/fpsyt.2022.976387. eCollection 2022.
Bromazepam-induced dystonia.
Pérez Trullen JM, Modrego Pardo PJ, Vázquez André M, López Lozano JJ.
Biomed Pharmacother. 1992;46(8):375-6. doi: 10.1016/0753-3322(92)90306-r.
Olanzapine for schizophrenia.
Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.
Cochrane Database Syst Rev. 2003;(1):CD001359. doi: 10.1002/14651858.CD001359.
